EL
MBIO icon

EMFO LLC’s Mustang Bio MBIO Stock Holding History

EMFO LLC’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43
Closed -$15K – 313
2022
Q3 		$15K Hold
43
– – 0.01% 234
2022
Q2 		$19K Hold
43
– – 0.02% 227
2022
Q1 		$32K Hold
43
– – 0.03% 210
2021
Q4 		$53K Buy
43
+2
+5% +$3.23K 0.05% 197
2021
Q3 		$83K Hold
41
– – 0.07% 163
2021
Q2 		$103K Buy
+41
New +$100K 0.09% 147

Other funds holding MBIO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

EMFO LLC's MBIO Position: Q4 2022 in Review

EMFO LLC sold out of Mustang Bio (MBIO) in Q4 2022, closing a stake of 43 shares — an estimated $15K sold.

EMFO LLC first reported a position in MBIO in Q2 2021 and held it in 6 quarters. The position peaked at $103K in Q2 2021. 60 funds tracked by Wall St. Rank hold MBIO as of Q4 2022.

  • EMFO LLC reported no remaining Mustang Bio position as of Q4 2022 after selling out during the quarter.
  • EMFO LLC sold 43 Mustang Bio shares in Q4 2022, an estimated $15K.
  • EMFO LLC first reported a position in Mustang Bio in Q2 2021 and held it in 6 quarters.
  • EMFO LLC's Mustang Bio position peaked at $103K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2022.

Based on EMFO LLC's 13F filing for Q4 2022, filed 2 Feb 2023.